Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A24274 | 23059407 | J Clin Gastroenterol | Primary biliary cirrhosis is more severe in overweight patients. | 2013 | Details |
A24281 | 23042372 | Minerva Med | Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic steatohepatitis scores. | 2012 | Details |
A24290 | 23034128 | J Gastroenterol Hepatol | Treatment of non-alcoholic steatohepatitis with Phyllanthus urinaria: a randomized trial. | 2013 | Details |
A24292 | 23032985 | Am J Gastroenterol | The interaction of rs738409, obesity, and alcohol: a population-based autopsy study. | 2012 | Details |
A24294 | 23032979 | Am J Gastroenterol | Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. | 2012 | Details |
A24298 | 23028442 | PLoS One | Metformin prevents and reverses inflammation in a non-diabetic mouse model of nonalcoholic steatohepatitis. | 2012 | Details |
A24303 | 23023916 | Magn Reson Med | In vivo (1)H-MRS hepatic lipid profiling in nonalcoholic fatty liver disease: an animal study at 9.4 T. | 2012 | Details |
A24305 | 23022698 | Clin Gastroenterol Hepatol | Association between anthropometric parameters and measurements of liver stiffness by transient elastography. | 2012 | Details |
A24309 | 24683373 | Gastroenterol Hepatol (N Y) | Noninvasive Diagnosis of NASH and Liver Fibrosis Within the Spectrum of NAFLD. | 2012 | Details |
A24313 | 23012396 | Physiol Genomics | Effects of perilipin 2 antisense oligonucleotide treatment on hepatic lipid metabolism and gene expression. | 2012 | Details |
A24316 | 23006461 | Saudi J Gastroenterol | Serum TGF-β, Serum MMP-1, and HOMA-IR as non-invasive predictors of fibrosis in Egyptian patients with NAFLD. | 2013 | Details |
A24319 | 23000435 | J Hepatol | Liver transplantation for hepatocellular carcinoma in a patient with a novel telomerase mutation and steatosis. | 2012 | Details |
A24328 | 22996622 | Hepatology | Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause? | 2013 | Details |
A24331 | 22991207 | Physiol Genomics | Dietary fat source alters hepatic gene expression profile and determines the type of liver pathology in rats overfed via total enteral nutrition. | 2012 | Details |
A24332 | 22990555 | Rom J Morphol Embryol | Association between liver histology, carotid ultrasonography and retinal vascular changes in patients with nonalcoholic fatty liver disease (NAFLD). | 2012 | Details |
A24337 | 22987396 | Hepatology | Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice. | 2013 | Details |
A24343 | 22982943 | Gastroenterology | Sterile inflammation in the liver. | 2012 | Details |
A24345 | 22981383 | Biochem Pharmacol | Endogenously synthesized n-3 polyunsaturated fatty acids in fat-1 mice ameliorate high-fat diet-induced non-alcoholic fatty liver disease. | 2012 | Details |
A24355 | 22973538 | G3 (Bethesda) | Quantitative trait loci affecting liver fat content in mice. | 2012 | Details |
A24357 | 22971072 | Hepatol Res | Association of chitotriosidase genotype with the development of non-alcoholic fatty liver disease. | 2012 | Details |
A24358 | 22970906 | Clin Sci (Lond) | NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses. | 2013 | Details |
A24372 | 22962039 | Pediatr Obes | Analysis of adipokine concentrations in paediatric non-alcoholic fatty liver disease. | 2012 | Details |
A24389 | 22942630 | Int J Angiol | Carotid intima-media thickness and liver histology in hemodialysis patients with nonalcoholic Fatty liver disease. | 2011 | Details |
A24390 | 22941955 | Hepatology | Tumor necrosis factor receptor 1 gain-of-function mutation aggravates nonalcoholic fatty liver disease but does not cause insulin resistance in a murine model. | 2013 | Details |
A24391 | 22941015 | Recent Results Cancer Res | Surgical resection for hepatocellular carcinoma in the noncirrhotic: the Western experience. | 2013 | Details |
A24400 | 22934189 | Int J Hepatol | Nonalcoholic Fatty liver disease in chronic hepatitis B and C patients from Western Amazon. | 2012 | Details |
A24402 | 22934006 | Front Physiol | Liver fibrogenesis in non-alcoholic steatohepatitis. | 2012 | Details |
A24403 | 22933860 | Gastroenterol Hepatol (N Y) | Hepatitis C virus infection and nonalcoholic steatohepatitis. | 2012 | Details |
A24409 | 22930399 | Hepatology | Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease. | 2013 | Details |
A24410 | 22927922 | PLoS One | Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic fatty liver disease. | 2012 | Details |
A24411 | 22927782 | ScientificWorldJournal | The effectiveness of liraglutide in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus compared to sitagliptin and pioglitazone. | 2012 | Details |
A24414 | 22923210 | J Gastrointest Surg | Influence of hepatic parenchymal histology on outcome following right hepatic trisectionectomy. | 2012 | Details |
A24416 | 22922372 | J Pediatr Gastroenterol Nutr | Transient elastography is a useful noninvasive tool for the evaluation of fibrosis in paediatric chronic liver disease. | 2013 | Details |
A24420 | 22915297 | J Nutr | Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis. | 2012 | Details |
A24424 | 22912545 | World J Gastroenterol | Overview and developments in noninvasive diagnosis of nonalcoholic fatty liver disease. | 2012 | Details |
A24431 | 22902548 | J Hepatol | Exposure to ambient particulate matter induces a NASH-like phenotype and impairs hepatic glucose metabolism in an animal model. | 2012 | Details |
A24432 | 22899556 | Hepatology | Determination of reliability criteria for liver stiffness evaluation by transient elastography. | 2013 | Details |
A24441 | 22890552 | Lab Invest | Increased intrahepatic resistance in severe steatosis: endothelial dysfunction, vasoconstrictor overproduction and altered microvascular architecture. | 2012 | Details |
A24444 | 22886508 | J Gastroenterol | Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis. | 2012 | Details |
A24446 | 22884488 | Clin Biochem | Serum levels of pigment epithelium-derived factor (PEDF) are independently associated with procollagen III N-terminal peptide levels in patients with nonalcoholic fatty liver disease. | 2012 | Details |
A24447 | 22884299 | Clin Res Hepatol Gastroenterol | PNPLA3, a genetic marker of progressive liver disease, still hiding its metabolic function? | 2012 | Details |
A24455 | 22876924 | Curr Med Chem | Adiponectin: key player in the adipose tissue-liver crosstalk. | 2012 | Details |
A24457 | 22876042 | World J Gastroenterol | Non-invasive determination of hepatic steatosis by acoustic structure quantification from ultrasound echo amplitude. | 2012 | Details |
A24459 | 22876027 | World J Gastroenterol | Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease. | 2012 | Details |
A24465 | 22871498 | J Hepatol | Development and validation of a new histological score for pediatric non-alcoholic fatty liver disease. | 2012 | Details |
A24466 | 22869157 | J Gastroenterol | The impact of patatin-like phospholipase domain-containing protein 3 polymorphism on hepatocellular carcinoma prognosis. | 2012 | Details |
A24470 | 22864259 | Eur J Gastroenterol Hepatol | Ursodeoxycholic acid for nonalcoholic steatohepatitis. | 2012 | Details |
A24478 | 22855443 | Dongwuxue Yanjiu | [Effects of resistin on hepatic fibrosis: possible mechanisms in non-alcoholic fatty liver disease in in vitro and in vivo]. | 2012 | Details |
A24484 | 22848440 | PLoS One | Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease. | 2012 | Details |
A24489 | 22846210 | Dis Markers | Concentrations of connective tissue growth factor in patients with nonalcoholic fatty liver disease: association with liver fibrosis. | 2012 | Details |
A24494 | 22841522 | Metabolism | Helicobacter pylori infection in patients with nonalcoholic fatty liver disease. | 2012 | Details |
A24496 | 22840293 | Gastrointest Endosc | Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study. | 2012 | Details |
A24509 | 22824481 | Clin Liver Dis | Can NASH be diagnosed, graded, and staged noninvasively? | 2012 | Details |
A24510 | 22824480 | Clin Liver Dis | Mechanisms of disease progression in NASH: new paradigms. | 2012 | Details |
A24513 | 22824477 | Clin Liver Dis | The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis. | 2012 | Details |
A24518 | 22820478 | J Hepatol | Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery. | 2012 | Details |
A24524 | 22809960 | Dig Liver Dis | Increased insulinogenic index is an independent determinant of nonalcoholic fatty liver disease activity score in patients with normal glucose tolerance. | 2012 | Details |
A24531 | 22796457 | Clin Gastroenterol Hepatol | Noninvasive assessment of nonalcoholic fatty liver disease in obese or overweight patients. | 2012 | Details |
A24535 | 22795319 | Clin Res Hepatol Gastroenterol | Does fructose consumption contribute to non-alcoholic fatty liver disease? | 2012 | Details |
A24537 | 22790906 | Dig Dis Sci | Liver stiffness measurements in patients with different stages of nonalcoholic fatty liver disease: diagnostic performance and clinicopathological correlation. | 2012 | Details |
A24539 | 22789032 | Clin Endocrinol (Oxf) | Fatty liver and insulin resistance in children with hypobetalipoproteinemia: the importance of aetiology. | 2013 | Details |
A24541 | 22780848 | Hepatol Res | Plasma free choline is a novel non-invasive biomarker for early-stage non-alcoholic steatohepatitis: A multi-center validation study. | 2012 | Details |
A24545 | 22768838 | Cell Metab | Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling. | 2012 | Details |
A24547 | 22768812 | Rev Med Inst Mex Seguro Soc | Hepatic steatosis and type 2 diabetes mellitus in health workers. | 2012 | Details |
A24551 | 22760655 | Semin Liver Dis | Nonalcoholic fatty liver disease and HIV infection. | 2012 | Details |
A24553 | 22753171 | Hepatology | Elovl6 promotes nonalcoholic steatohepatitis. | 2012 | Details |
A24554 | 22753133 | Hepatology | Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus. | 2012 | Details |
A24558 | 22751227 | Eur J Gastroenterol Hepatol | Etiologic types of end-stage chronic liver disease in adults: analysis of prevalence and their temporal changes from a study on native liver explants. | 2012 | Details |
A24569 | 22740341 | Liver Transpl | Evolution of nonalcoholic fatty liver disease recurrence after liver transplantation. | 2012 | Details |
A24571 | 22739374 | J Nutr | Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice. | 2012 | Details |
A24575 | 22735605 | Eur J Gastroenterol Hepatol | How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease. | 2012 | Details |
A24577 | 22734967 | Clin Sci (Lond) | Kupffer cell depletion attenuates leptin-mediated methoxamine-stimulated portal perfusion pressure and thromboxane A2 release in a rodent model of NASH-cirrhosis. | 2012 | Details |
A24583 | 22724878 | Arch Iran Med | Sampling error in histopathology findings of nonalcoholic fatty liver disease: a post mortem liver histology study. | 2012 | Details |
A24585 | 22722431 | Dig Dis | Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment. | 2012 | Details |
A24589 | 22719876 | PLoS One | Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. | 2012 | Details |
A24593 | 22716237 | Histopathology | Aberrant cytokeratin 7 expression of centrilobular hepatocytes: a clinicopathological study. | 2012 | Details |
A24594 | 22715293 | Ann Clin Biochem | The glycated albumin to glycated haemoglobin ratio increases along with the fibrosis stage in non-alcoholic steatohepatitis. | 2012 | Details |
A24597 | 22710359 | Int J Mol Med | Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells. | 2012 | Details |
A24598 | 22707395 | Hepatology | Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. | 2012 | Details |
A24599 | 22707355 | Hepatology | Pioglitazone and vitamin E for nonalcoholic steatohepatitis: a cost utility analysis. | 2012 | Details |
A24600 | 22706738 | Turk J Gastroenterol | Effects of probiotics on methionine choline deficient diet-induced steatohepatitis in rats. | 2012 | Details |
A24605 | 22700625 | Ann Hepatol |  Gut microbiota and nonalcoholic fatty liver disease. | 2012 | Details |
A24611 | 22692288 | Adv Anat Pathol | Liver biopsy in modern clinical practice: a pediatric point-of-view. | 2012 | Details |
A24616 | 22688100 | Nihon Shokakibyo Gakkai Zasshi | [Validity of the NAFLD fibrosis score in a Japanese population]. | 2012 | Details |
A24625 | 22677947 | Recenti Prog Med | [Hepatic steato-fibrosis and non-alcoholic liver disease in elderly]. | 2012 | Details |
A24631 | 22672642 | Liver Int | Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. | 2012 | Details |
A24633 | 22672485 | J Am Acad Nurse Pract | Nonalcoholic fatty liver disease: the hepatic metabolic syndrome. | 2012 | Details |
A24634 | 22672330 | Diabet Med | Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management. | 2012 | Details |
A24635 | 22672067 | Australas J Dermatol | The increased prevalence of non-alcoholic fatty liver disease in psoriatic patients: a study from South India. | 2012 | Details |
A24641 | 22659415 | Biochem Biophys Res Commun | GH-independent IGF-I action is essential to prevent the development of nonalcoholic steatohepatitis in a GH-deficient rat model. | 2012 | Details |
A24647 | 22652341 | Drug Discov Today | Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis. | 2012 | Details |
A24652 | 22648049 | Eur Radiol | Detection of non-alcoholic steatohepatitis in patients with morbid obesity before bariatric surgery: preliminary evaluation with acoustic radiation force impulse imaging. | 2012 | Details |
A24653 | 22646469 | Platelets | Mean platelet volume in biopsy-proven non-alcoholic fatty liver disease. | 2012 | Details |
A24655 | 25755424 | J Clin Exp Hepatol | Management of Non-alcoholic Fatty Liver Disease and Steatohepatitis. | 2012 | Details |
A24656 | 25755423 | J Clin Exp Hepatol | Non-invasive Diagnosis of Fibrosis in Non-alcoholic Fatty Liver Disease. | 2012 | Details |
A24658 | 25755421 | J Clin Exp Hepatol | Non-alcoholic Fatty Liver Disease: East Versus West. | 2012 | Details |
A24682 | 22612998 | J Hepatol | Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: proof of concept and first application in a large population. | 2012 | Details |
A24686 | 22610002 | Clin Gastroenterol Hepatol | Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver disease. | 2012 | Details |
A24687 | 22609320 | Eur J Radiol | Elastographic assessment of liver fibrosis in children: A prospective single center experience. | 2012 | Details |
A24692 | 22593713 | ScientificWorldJournal | Deficiency in galectin-3 promotes hepatic injury in CDAA diet-induced nonalcoholic fatty liver disease. | 2012 | Details |